SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001564590-19-013383
Filing Date
2019-04-26
Accepted
2019-04-26 16:54:40
Documents
15
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 20-F/A ortx-20fa_20181231.htm 20-F/A 70716
2 EX-4.12 ortx-ex412_7.htm EX-4.12 720233
3 EX-12.1 ortx-ex121_6.htm EX-12.1 24420
4 EX-12.2 ortx-ex122_8.htm EX-12.2 24192
5 GRAPHIC gjllb4wm3ime000009.jpg GRAPHIC 44040
6 GRAPHIC gjllb4wm3ime000007.jpg GRAPHIC 36225
7 GRAPHIC gjllb4wm3ime000006.jpg GRAPHIC 89339
8 GRAPHIC gjllb4wm3ime000001.jpg GRAPHIC 21245
9 GRAPHIC gjllb4wm3ime000008.jpg GRAPHIC 51314
10 GRAPHIC gjllb4wm3ime000011.jpg GRAPHIC 25747
11 GRAPHIC gjllb4wm3ime000003.jpg GRAPHIC 48097
12 GRAPHIC gjllb4wm3ime000005.jpg GRAPHIC 97640
13 GRAPHIC gjllb4wm3ime000002.jpg GRAPHIC 28941
14 GRAPHIC gjllb4wm3ime000004.jpg GRAPHIC 97342
15 GRAPHIC gjllb4wm3ime000010.jpg GRAPHIC 41448
  Complete submission text file 0001564590-19-013383.txt   1642787
Mailing Address 108 CANNON STREET LONDON X0 EC4N 6EU
Business Address 108 CANNON STREET LONDON X0 EC4N 6EU 011-44-0-203-3846700
Orchard Therapeutics plc (Filer) CIK: 0001748907 (see all company filings)

IRS No.: 000000000
Type: 20-F/A | Act: 34 | File No.: 001-38722 | Film No.: 19772495
SIC: 2836 Biological Products, (No Diagnostic Substances)